← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksPHGERevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

PHGE logoBiomX Inc. (PHGE) Revenue History

Annual and quarterly revenue from 2017 to 2024

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q3 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

Revenue Growth Metrics

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

8 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PHGE Revenue Analysis (2017–2024)

As of March 5, 2026, BiomX Inc. (PHGE) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.

Looking at the longer-term picture, PHGE's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including ARMP (-7.6% YoY), EVGN (-26.2% YoY), and SYBX (-100.0% YoY). Compare PHGE vs ARMP →

Peer Comparison

Compare PHGE's revenue metrics with industry peers

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
PHGE logoPHGECurrent$0---
ARMP logoARMP$5M-7.6%--820.2%
EVGN logoEVGN$9M-26.2%+62.4%-255.4%
SYBX logoSYBX$8,000-100.0%-67.6%-511875.0%
ELAB logoELAB$2M-179.8%--75.7%
Best in groupLowest in group

Historical Revenue Data

Showing 8 of 8 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2024$0-$-1,803,000-$-39,027,000-
2023$0-$-871,000-$-27,685,000-
2022$0-$0-$-27,219,000-
2021$0-$0-$-35,462,000-
2020$0-$0-$-30,258,000-
2019$0-$0-$-22,207,000-
2018$0-$-210,000-$-13,141,000-
2017$0-$-95,000-$-7,372,000-

See PHGE's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is PHGE Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare PHGE vs LLY

See how PHGE stacks up against sector leader Eli Lilly and Company.

Start Comparison

Frequently Asked Questions

Is PHGE's revenue growth accelerating or slowing?

PHGE TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is PHGE's long-term revenue growth rate?

BiomX Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is PHGE's revenue distributed by segment?

PHGE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.

Revenue Over Time